Oral Cancer: Page 26

Study: Blood, saliva tests may aid early HNC detection
By Donna Domino
Blood and saliva tests can identify DNA from head and neck cancers (HNCs), which could pave the way for noninvasive diagnostic tests, according to a new study in Science Translational Medicine. Such screening tests could lead to early diagnosis of these and other cancers.
July 1, 2015
2013 04 10 10 14 48 506 Cancer Cell 200
OHA launches annual slogan contest on dangers of spit tobacco
By DrBicuspid.com staff writers
Oral Health America (OHA) has launched its 14th annual National Spit Tobacco Project slogan contest.
June 30, 2015
Award funds oropharyngeal cancer outcomes study
By DrBicuspid.com staff writers
The Patient-Centered Outcomes Research Institute's Pipeline to Proposal program has given a clinical research award to an otolaryngologist with Henry Ford Hospital in Detroit to study treatment options and post-treatment rehabilitation for oropharyngeal cancer patients.
June 22, 2015
OncoSec enrolls 1st patient in immunotherapy clinical trial
By DrBicuspid.com staff writers
OncoSec Medical has enrolled the first patient in a phase II clinical trial that uses ImmunoPulse IL-12, an immunotherapy platform, to treat patients with squamous cell carcinoma of the head and neck.
June 17, 2015
Forward Science launches chairside test for oral pH
By DrBicuspid.com staff writers
Forward Science Technologies, the developer of the OralID cancer screening device, has added to its line of oral healthcare products with its new chairside oral pH test, called phID.
June 16, 2015
NCI grants $10M for HNC research
By DrBicuspid.com staff writers
The National Cancer Institute (NCI) has awarded the Roswell Park Cancer Institute of Buffalo, NY, a $10 million federal grant to continue its research program on photodynamic therapy, specifically in head and neck cancers.
June 16, 2015
Study: Pembrolizumab shows promise as HNC treatment
By Donna Domino
A new immunotherapy drug was found to be almost twice as effective as the preferred treatment for decreasing the size of the tumors of patients with recurrent or metastatic head and neck cancer (HNC), according to a study presented at the recent meeting of the American Society for Clinical Oncology.
June 15, 2015
2015 04 20 15 39 28 178 Cancer Cell Target 200
Study: Half of oral cancer deaths due to cigarettes
By DrBicuspid.com staff writers
Almost half of the deaths caused by cancers of the oral cavity and pharynx in U.S. adults age 35 and older in 2011 were attributable to cigarette smoking, according to a multi-institution research letter published June 15 in JAMA Internal Medicine.
June 14, 2015
2015 01 26 18 01 33 455 Cigarette Smoking 200
SNMMI: PET/CT predicts survival in head and neck cancer
By Wayne Forrest
BALTIMORE - FDG-PET and FDG-PET/CT do a good job in predicting the chances of recurrence and survival for patients with head and neck cancer within two years of completing chemotherapy treatment, according to a study presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 10, 2015
2015 06 10 14 41 29 65 Baltimore Harbor 200
Week in Review: 3 tips for clear communication; chemotherapy costs for oral cancer
By Tony Edwards
June 4, 2015
Study finds chemo costly for oral cancer in elderly
By Theresa Pablos
Medicare costs for elderly patients with oral and pharyngeal cancers are significantly impacted by treatment selection, according to a new study. Chemotherapy patients cost the program $32,000 more on average over five years than those who picked alternative treatments.
June 3, 2015
2014 06 16 09 56 39 590 Cancer Center 200
Oral cancer researcher receives $200K grant
By DrBicuspid.com staff writers
The Sidney Kimmel Foundation announced that oral stem cell researcher Scott Williams, PhD, is one of 15 recipients for the 2015 Kimmel Scholar Program and will receive two-year grants totaling $200,000.
May 28, 2015
Previous Page
Page 26 of 117
Next Page